Clinical experts and thought leaders present recent clinical data and critical insights on the biologic and clinical rationale of using checkpoint inhibitors as well as improving health disparities that exist among patients diagnosed with hepatobiliary cancers. This request includes 1-hour community hospital programs, which will be presented in an interactive format designed to specifically reinforce key learning objectives. This educational tool will be used to build a more interactive environment and provide the opportunity to apply case vignettes to capture more robust, subjective level 5 outcomes measurement data.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Pricing
All courses included · from $18.75/mo
Courses are included in the subscription; some are also sold individually.
| Student Flex | $18.75/mo |
| Professional Flex | $60/mo |
| Student 3-Year | $100 |
| Student 2-Year | $112.50 |
+4 more plans
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Maternal-Fetal Medicine
- Medical Leadership & Administration
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Plastic & Reconstructive Surgery
- Practice Management & Ethics
- Pulmonary Disease
- Sleep Medicine
- Surgical Oncology
- Thoracic Anesthesia
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Conference / congress
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedOct 5, 2026
-
Last day to claim creditOct 6, 2027 12 months left
-
Medical Learning Institute, Inc. Preserving Liver Function, Improving Long-term Survival & Enhancing Quality of Life in Patients with HCC
-
Answers in CME Inc. (AiCME) Redefining Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Are You Prepared?
-
PVI, PeerView Institute for Medical Education Raising the Game in Biliary Cancer: Adapting Rapidly Emerging Evidence and Achieving Optimal Disease Control With Immunotherapy and Targeted Platforms
-
Plexus Communications +1 Optimizing Checkpoint Inhibitor Therapy for Advanced Hepatobiliary Cancers
-
Plexus Communications +1 Transforming Care in Pancreatic Ductal Adenocarcinoma: Emerging Evidence and Clinical Implications
-
Plexus Communications +1 Advancing EGFR-Mutated NSCLC Management Across Practice Settings: Evidence-Based Approaches to Testing, Treatment Selection, and Sequencing
